Abstract
The cancer microenvironment and interaction between cancer and stromal cells play critical roles in tumor development and progression. The molecular features of cancer stroma are less well understood than those of cancer cells. Cancer-associated stromal fibroblasts are the predominant component of stroma associated with colon cancer and its functions remain unclear. Fibroblast cell cultures were established from metastatic colon cancer in liver, liver away from the metastatic lesions, and skin from three patients with metastatic colorectal cancer. We generated expression profiles of cancer-associated fibroblasts using oligochip arrays and compared them to those of uninvolved fibroblasts. The conditioned media from the cancer-associated fibroblast cultures enhanced proliferation of colon cancer cell line HCT116 to a greater extent than cultures from uninvolved fibroblasts. In microarray expression analysis, cancer-associated fibroblasts clustered tightly into one group and skin fibroblasts into another. Approximately 170 of 22 000 genes were up-regulated in cancer-associated fibroblasts (fold change>2, P<0.05) as compared to skin fibroblasts, including many genes encoding cell adhesion molecules, growth factors, and COX2. By immunohistochemistry in-vivo, we confirmed COX2 and TGFB2 expression in cancer-associated fibroblasts in metastatic colon cancer. The distinct molecular expression profiles of cancer-associated fibroblasts in colon cancer metastasis support the notion that these fibroblasts form a favorable microenvironment for cancer cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- BrdU:
-
bromodeoxyuridine
- CAFs:
-
Cancer-associated stromal fibroblasts
- DAPI:
-
4’6-diamidino-2-phenylindole dihydrochloride
- GAPDH:
-
glyceraldehyde-3-phosphate dehydrogenase
- PBS:
-
phosphate-buffered saline
- RT–PCR:
-
reverse transcriptase–polymerase chain reaction
References
Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM and Forbes JT . (1993). J. Clin. Invest., 92, 2569–2576.
Bajou K, Noel A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D and Foidart JM . (1998). Nat. Med., 4, 923–928.
Bartholin L, Maguer-Satta V, Hayette S, Martel S, Gadoux M, Corbo L, Magaud JP and Rimokh R . (2002). Oncogene, 21, 2227–2235.
Brattain MG, Brattain DE, Sarrif AM, McRae LJ, Fine WD and Hawkins JG . (1982). J. Natl. Cancer. Inst., 69, 767–771.
Camps JL, Chang SM, Hsu TC, Freeman MR, Hong SJ, Zhau HE, von Eschenbach AC and Chung LW . (1990). Proc. Natl. Acad. Sci. USA, 87, 75–79.
Conze D, Weiss L, Regen PS, Bhushan A, Weaver D, Johnson P and Rincon M . (2001). Cancer Res., 61, 8851–8858.
DeGregori J, Leone G, Ohtani K, Miron A and Nevins JR . (1995). Genes Dev., 9, 2873–2887.
Derynck R, Akhurst RJ and Balmain A . (2001). Nat. Genet., 29, 117–129.
Diehn M, Sherloc, G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T, Rees CA, Cherry JM, Botstein D, Brown PO and Alizadeh AA . (2003). Nucleic Acids Res., 31, 219–223.
Dignass AU, Tsunekawa S and Podolsky DK . (1994). Gastroenterology, 106, 1254–1262.
Dvorak HF . (1986). N. Engl. J. Med., 315, 1650–1659.
Eisen MB, Spellman PT, Brown PO and Botstein D . (1998). Proc. Natl. Acad. Sci. USA, 95, 14863–14868.
Elenbass B and Weinberg RA . (2001). Exp. Cell Res., 264, 169–184.
Folkman J . (1985). Adv. Cancer Res., 43, 175–203.
Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK and Seed B . (1998). Cell, 94, 715–725.
Gho YS, Kim PN, Li HC, Elkin M and Kleinman HK . (2001). Cancer Res., 61, 4253–4257.
Gleave M, Hsieh J, Gao C, von Eschenbach AC and Chung WK . (1991). Cancer Res., 51, 3753–3761.
Hanahan D and Weinberg RA . (2000). Cell, 100, 57–70.
Hill DP, Blake JA, Richardson JE and Ringwald M . (2002). Genome Res., 12, 1982–1991.
Holen I, Croucher PI, Hamdy FC and Eaton CL . (2002). Cancer Res., 62, 1619–1623.
Li C and Wong WH . (2001). Proc. Natl. Acad. Sci. USA, 98, 31–36.
Liotta LA and Kohn EC . (2001). Nature, 411, 375–379.
Matrisian LM, Cunha GR and Mohla S . (2001). Cancer Res., 61, 3844–3846.
Miyakoshi N, Richman C, Kasukawa Y, Linkhart TA, Baylink DJ and Mohan S . (2001). J. Clin. Invest., 107, 73–81.
Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E and Zlotnik A . (2001). Nature, 410, 50–56.
Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P and Rosenbaum J . (1997). Hepatology, 26, 1458–1466.
Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evan JM and Taketo MM . (1996). Cell, 87, 803–809.
Paget S . (1889). Lancet, 1, 571–573.
Picard O, Rolland Y and Poupon MF . (1986). Cancer Res., 46, 3290–3294.
Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI and West AB . (1999). Am. J. Physiol., 277, 1–19.
Schmitt-Gräff A, Desmouliere A and Gabbiani G . (1994). Virchows Arch., 425, 3–24.
Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ and Andreeff M . (2002). Cancer Res., 62, 3603–3608.
Tlsty TD . (2001). Cancer Biol., 11, 97–104.
Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, Bloomfield, CD, de la Chapelle A and Krahe R . (2001). Proc. Natl. Acad. Sci. USA, 98, 1124–1129.
Westermark B and Heldin CH . (1991). Cancer Res., 51, 5087–5092.
Williams CS, Tsujii M, Reese J, Dey SK and Dubois RD . (2000). J. Clin. Invest., 105, 1589–1594.
Youngs SJ, Ali SA, Taub DD and Rees RC . (1997). Int. J. Cancer, 71, 257–266.
Acknowledgements
We thank J Palatini and D Newsom for their technical assistance with microarrays, and S Jones for her technical assistance with immunohistochemistry. This work was supported by grants CA67941 and CA16058 from the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakagawa, H., Liyanarachchi, S., Davuluri, R. et al. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 23, 7366–7377 (2004). https://doi.org/10.1038/sj.onc.1208013
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208013
Keywords
This article is cited by
-
Intimate communications within the tumor microenvironment: stromal factors function as an orchestra
Journal of Biomedical Science (2023)
-
Establishment of cancer-associated fibroblasts-related subtypes and prognostic index for prostate cancer through single-cell and bulk RNA transcriptome
Scientific Reports (2023)
-
Facile preparation of aqueous-soluble fluorescent polyethylene glycol functionalized carbon dots from palm waste by one-pot hydrothermal carbonization for colon cancer nanotheranostics
Scientific Reports (2022)
-
Importance of the origin of mesenchymal (stem) stromal cells in cancer biology: “alliance” or “war” in intercellular signals
Cell & Bioscience (2021)
-
Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells’ heterogeneity
Nature Communications (2020)